Evidence map›Paper›PMID 37153250›Full record

ArticleCureus2023

Giant Soft Tissue Leiomyosarcoma of the Left Lower Extremity: Case Presentation With a Review of the Literature.

Giovanni De Biasi, Gerardo Cazzato, Anna Colagrande, Eugenio Maiorano, Giuseppe Ingravallo

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Rare case of giant ischiorectal leiomyosarcoma.International journal of surgery case reports · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Giovanni De BiasiDepartment of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Section of Molecular Pathology, University of Bari "Aldo Moro", Bari, ITA.
Gerardo CazzatoDepartment of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Section of Molecular Pathology, University of Bari "Aldo Moro", Bari, ITA.
Anna ColagrandeDepartment of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Section of Molecular Pathology, University of Bari "Aldo Moro", Bari, ITA.
Eugenio MaioranoDepartment of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, ITA.
Giuseppe IngravalloDepartment of Emergency and Organ Transplantation, Section of Pathology, University of Bari "Aldo Moro", Bari, ITA.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leiomyosarcoma (LMS) accounts for approximately 5-10% of soft tissue sarcomas, with an estimated incidence in the United States (US) of less than one case/200,000 persons, more frequent in women than men. Approximately two-thirds of LMSs are retroperitoneal, abdominal, and mediastinal. Localized, soft tissue LMSs represent a lower percentage, with the lower limbs and trunk being the most frequently involved sites. LMSs larger than 5 cm (so-called giants) are even rarer, and to date have been little reported in the literature. In this paper, we present the case of a giant LMS of the left lower limb in a 73-year-old patient, who had a mass for about two years, and who, after the first diagnostic biopsy, underwent limb amputation. Macroscopic and microscopic examinations confirmed the infiltration of the underlying tibial bone. We briefly discuss eight other cases described in the literature with similar size, pointing out that the parameters with the greatest impact on prognosis proved to be size >5 cm and depth of invasion. Due to the rarity of this neoplasm, little has yet been done in relation to the most suitable therapeutic treatment of such patients, and larger case series are mandated in order to be able to conduct broader-spectrum studies.

Indexed as

boneoncology soft tissuepathologysoft tissue tumourstrauma and orthopedics

Identifiers

PMID37153250
PMCPMC10155594
OpenAlexW4362580456

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.